JAKARTA, Indonesia -- Eight hospitals in Indonesia are set to conduct clinical trials on Ivermectin, an anti-parasitic medicine that has appeared to be a potential COVID-19 medication, following a permit issued by the national agency of drug and food control (BPOM). BPOM's head Penny K. Lukito said...